Brief Reports
Copyright ©The Author(s) 2003.
World J Gastroenterol. Aug 15, 2003; 9(8): 1848-1852
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1848
Table 1 Clinicopathological data of hyperglycemic and non-hyperglycemic patients with HCC
VariablesWith hyperglycemia (n = 28)Wthout hyperglycemia (n = 197)
Age (year)55 ± 1.9951.91 ± 1.08
HBsAg(+/-)15/13110/87
Cirrhosis (+/-)20/8133/64
Gender (male/female)23/5157/40
Laboratory data
ALT (U/L)48.91 ± 10.4139.82 ± 11.21
PT (s)12.24 ± 0.2012.67 ± 0.23
Albumin (g/L)39.63 ± 6.3535.81 ± 7.86
Total bilirubin (μmmol/L)12.32 ± 7.1513.54 ± 8.97
Platelet count ( × 109/L)158.41 ± 18.14155.75 ± 7.37
TNM stage (I/II/III/IVa/IVb)a0/3/12/5/80/32/76/48/41
Child-Pugh grades (A/B/C)22/5/1165/30/2
Sizes of the largest tumor (cm)3.80 ± 6.303.50 ± 6.75
Initial treatment (TACE/radiotherapy/ TACE+radiotherapy/ PEI/biotherapy)18/3/5/3/15128/17/15/11/147